Live Breaking News & Updates on Institutional Investors Weigh In On Ironwood Pharmaceuticals

Stay updated with breaking news from Institutional investors weigh in on ironwood pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Andrew Davis Sells 9,846 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stock

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) SVP Andrew Davis sold 9,846 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $15.24, for a total value of $150,053.04. Following the transaction, the senior vice president now owns 208,324 shares in the company, […] ....

Baja California Sur , United States , Craig Hallum , Andrew Davis , Wells Fargo Company , Vanguard Group Inc , Quarter For Ironwood Pharmaceuticals , Ironwood Pharmaceuticals Company Profile , Ironwood Pharmaceuticals , Ironwood Pharmaceuticals Price Performance , Blackrock Inc , News Ratings For Ironwood Pharmaceuticals Daily , Armistice Capital , Jefferies Financial Group , Ironwood Pharmaceuticals Inc , Institutional Investors Weigh In On Ironwood Pharmaceuticals , Get Free Report , Financial Group , Wells Fargo , Street Corp , Ironwood Pharmaceuticals Daily , Nasdaq Irwd , Insider Trading , Nsider Trades ,

Ironwood Pharmaceuticals (NASDAQ:IRWD) Hits New 1-Year High at $14.30

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) shares hit a new 52-week high on Monday . The company traded as high as $14.30 and last traded at $14.30, with a volume of 806 shares traded. The stock had previously closed at $13.39. Analyst Ratings Changes A number of equities analysts recently weighed in on […] ....

United States , Craig Hallum , News Ratings For Ironwood Pharmaceuticals Daily , Ironwood Pharmaceuticals Price Performance , Institutional Investors Weigh In On Ironwood Pharmaceuticals , Ironwood Pharmaceuticals , Ironwood Pharmaceuticals Inc , Jefferies Financial Group , Raymond James Associates , Cetera Advisor Networks , Metlife Investment Management , Wells Fargo Company , Financial Services Group Inc , Ironwood Pharmaceuticals Company Profile , Get Free Report , Financial Group , Advisor Networks , Services Group , Life Investment Management , Rhumbline Advisers , Ironwood Pharmaceuticals Daily , Nasdaq Irwd ,

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 5.2%

Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) traded up 5.2% during trading on Wednesday . The stock traded as high as $12.47 and last traded at $12.35. 626,306 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 3,420,595 shares. The stock had previously closed at […] ....

United States , Craig Hallum , Ironwood Pharmaceuticals Company Profile , Raymond James Financial Services Advisors Inc , Institutional Investors Weigh In On Ironwood Pharmaceuticals , Ironwood Pharmaceuticals , Vanguard Group Inc , Walleye Capital , Jefferies Financial Group , News Ratings For Ironwood Pharmaceuticals Daily , Ironwood Pharmaceuticals Inc , American Century Companies Inc , Ironwood Pharmaceuticals Stock Performance , Wells Fargo Company , Get Free Report , Financial Group , James Financial Services Advisors , Employees Retirement System , Century Companies , Ironwood Pharmaceuticals Daily , Nasdaq Irwd ,

Ironwood Pharmaceuticals (NASDAQ:IRWD) Coverage Initiated at Wells Fargo & Company

Wells Fargo & Company assumed coverage on shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) in a research report released on Thursday morning, MarketBeat.com reports. The firm issued an overweight rating and a $20.00 price objective on the biotechnology company’s stock. Other equities analysts also recently issued reports about the stock. Jefferies Financial Group initiated […] ....

United States , Institutional Investors Weigh In On Ironwood Pharmaceuticals , Jefferies Financial Group , News Ratings For Ironwood Pharmaceuticals Daily , Ironwood Pharmaceuticals Inc , Wells Fargo Company , China Universal Asset Management Co , Headlands Technologies , Ironwood Pharmaceuticals , Ironwood Pharmaceuticals Stock Performance , Financial Services Group Inc , Goodman Advisory Group , Wells Fargo , Free Report , Financial Group , Moderate Buy , Get Free Report , Advisory Group , Universal Asset Management , Services Group , Ironwood Pharmaceuticals Daily , Nasdaq Irwd , Initiated Coverage ,

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) from a buy rating to a strong-buy rating in a research report released on Tuesday morning. Separately, Piper Sandler upped their price objective on shares of Ironwood Pharmaceuticals from $16.00 to $19.00 in a research note on Tuesday, May 23rd. Ironwood Pharmaceuticals Stock Performance Shares […] ....

United States , Piper Sandler , Thomasa Mccourt , Securities Exchange Commission , Ironwood Pharmaceuticals , Ironwood Pharmaceuticals Stock Performance , News Ratings For Ironwood Pharmaceuticals Daily , Institutional Investors Weigh In On Ironwood Pharmaceuticals , Millennium Management , Ironwood Pharmaceuticals Inc , Norges Bank , Get Rating , Exchange Commission , Street Corp , Sigma Investments , Two Sigma Advisers , Sigma Advisers , Ironwood Pharmaceuticals Daily , Nasdaq Irwd , Stocknews Com ,